Norethisterone ethanate (200 mg every 84 days) and medroxyprogesterone acetate (150 mg every three months) were found to be completely effective in fertility control when started in the puerperium. Neither agent had any ill effect on the amount of milk or the duration of lactation. From the third month onward the three-hourly available milk and the infant weight gain per month were statistically higher in treated groups than in controls. Milk proteins showed a slight decrease in most groups, including the controls, owing to the low-protein diet.
Introduction
The rapid increase in birth rate in the U.A.R. has encouraged the adoption of birth control programmes on a wide scale; all available methods of contraception are being used. In the present decade the conventional methods of contraception are being superseded by pills, intrauterine devices (I.U.D.), and more recently by the injection of contraceptives.
Contraception in the postpartum period should be an integral part of any birth control programmne. Problems, however, arise when choosing an appropriate contraceptive method in the early puerperium. I.U.D.s have a high expulsion rate and a risk of perforation when applied shortly after delivery. Pills (containing oestrogens and progestogens) are claimed to affect lactation adversely (Rice-Wray, 1964; Pincus, 1965; Turabi et al., 1966; Kammal et al., 1968) . The effect of injected progestogens on lactation, however, has had little consideration. This paper deals with the assessment of the quantitative and qualitative effects of injected progestogens on lactation and on the breast-fed infant.
Material and Method
The trial was started in March 1969 at the birth control clinic of Ain Shams University Hospital, and many cases have been followed for more than 18 months. Our social workers contacted normally delivered patients in the obstetric wards and collected 331 cases of about the same socioeconomic standards; their average age and parity are given in Table I .
The cases were divided into three groups: group 1 consisted of 100 cases followed up from the seventh postpar- was not repeated. It was usually moderate in amount; when troublesome it was stopped by the administration of oral ethinyloestradiol 0-02 mg, two tablets a day for five days. Effect on Uterine Involution.-Uterine involution proceeded normally in all patients who started treatment on the seventh postpartum day. The difference between the length of uterine cavity and duration of lochia in treated groups and controls was not statistically significant.
Side Effects.-There were no important side effects other than menstrual disorders.
Re-establishment of Fertility.-Among the 33 who discontinued the trial seven wanted pregnancy and did not adopt any contraceptive measures. In the three who used norethisterone acetate pregnancy occurred after five to seven months. In the four who used medroxyprogesterone acetate pregnancy did not occur until after an average of eight months.
Importance of Starting Contraception in Puerperium.-Analysis of the history showed that 2066% of 1,440 pregnancies had occurred during previous lactations, over half of these were undesired and more than one-third of them occurred within three months of parturition.
Effect on Lactation and Breast-fed Infant.-As lactation may be affected by quality and quantity of food a nutritional analysis of all groups was performed (Table III) . It showed that all groups consume a more or less comparable percentage of essential requirements of different foodstuffs. The protein intake, particularly animal protein, was rather low.
History of Previous Lactation.-The average duration of previous full lactation was statistically identical in the different groups; it ranged between 6.49 and 6-83 months. Table IV ). Differences between treated groups were not significant.
Average Three-hourly Available Milk.-After the third month there was a significant increase (P<0-05) in the treated groups compared with the controls. From the fourth month onward the increase was highly significant (P<0-01).
Biochemical Results.-Milk fat, lactose, and total solids (Table VI) showed a slight increase after two, four, and six months of therapy. The variations, however, were not statistically significant (P>0.05). The average milk proteins, however, showed a statistically significant (P<0-05) decrease in most groups, including the controls (Table VII) .
Effect on Breast-fed Infant.-The follow-up of babies of treated mothers and controls up to 18 months did not show (40) 2a (40) |2b (40) A (40) B (40) any physical, mental or radiological abnormality. These children will be followed up for several years.
Discussion
It is essential to practise contraception in the puerperium as conception is apt to occur after the sixth postpartum week, when ovulation may be resumed (Sharman, 1951) . In the present series 20-6% of previous pregnancies had occurred during previous lactations and more than one-third of them occurred before the third month after parturition. Norethisterone ethanate and medroxyprogesterone acetate proved to be highly effective in controlling fertility when started in the puerperium. In order to evaluate their effects on lactation other factors, such as age-parity, previous full lactations, socioeconomic and nutritional standards, that may influence physiology of lactation were comparable in the different groups of the trial. Our results indicate that these pure progestogens produced no ill effect on lactation. They may, however, maintain a good milk supply after the third postpartum month, and probably they delayed involutionary changes that were found to occur in the breast in control cases about this tirne.
The average three-hourly available milk was therefore higher in the treated groups than in controls after the third postpartum month. The significant increase in average growth curves and weight gain per month of infants of treated mothers over those of controls reflect to a fair extent the available milk yield, as supplementation was avoided during the first six months of the trial.
The possibility, however, of secretion of progesterone in breast milk and its effect on infant growth cannot be excluded. Dalton (1968) reported that children of mothers who were treated with progesterone for toxaemia during pregnancy were found to be heavier than those of controls and stressed that more progesterone children were breast-fed until six months. G6mez-Rogers et al. (1967) reported that the use of 500 mg of medroxyprogesterone acetate as a six-monthly contraceptive did not affect lactation. These progestogens did not affect the milk constituents. The decrease in milk protein reported in most groups is believed to be due to low protein intake in this class of women, as proved by nutritional analysis. They have therefore to call on body proteins for synthesis of milk proteins.
There is a distinct divergence of opinion regarding the effect of oestrogen and progesterone on lactation. Several authors (Nelson, 1934 (Nelson, , 1936 Ansilmino and Hoffman, 1936) have pointed out that oestrogen and progesterone inhibit lactation in animals; others (Seyle, 1940; Mayer and Klein, 1949; Meites and Turner, 1961) believe that progesterone is the predominant factor. Folley (1956) concluded that oestrogen in small doses stimulates and in large doses inhibits the mammary gland. The addition of progesterone renders the stimulating dose inhibitory. Joshi and Rao (1968) pointed outhat different animal species differed in their response to oestrogen and progesterone. Chinnatamby (1967) stressed that higher doses of progesterone significantly reduced the duration of lactation in women. Satterthwaite and Gambel (1962) reported a diminished flow of milk after the first or second cycle on using 5 and 10 mg of norethynodrel. Rudel et al (1965) , on the other hand, using continuous treatment with oral progesterone chlormadinone, found that it had no inhibitory effect on lactation. Kammal et al. (1968) reported a decrease in milk fat and proteins in those receiving Lyndiol 2-5 and 1, continuous lynoestrenol (0-5 mg), or long-acting injectable steroid Deladroxate (150 mg dihydroxyprogesterone acetaphenide + 10 mg oestradiol ethanate). Ferin et al. (1964) , however, reported no effect on quality or quantity of milk in lactating women taking 2-5 and 5 mg lynoestrenol.
When started during the puerperium the prozestogens we used did not produce any significant side effects except frequent amenorrhoea. As amenorrhoea occurs normally during this period it was not troublesome to the users. This is certainly shown by the acceptability of this method, which reached more than 85 ,. We believe that the seventh postpartum day may represent an optimum date for starting contraceptive injection, as women are easily motivated after delivery, and they can be included in the contracention programme before they are discharged from hospital. If the drug action reouires a lag period to be fully established it will coincide with that of physiological sterility. On the other hand, the injection may be given in the sixth postpartum week, when women came for postnatal examination.
Many patients, fearing the effect of pills on lactation, start taking the pills too late; injectable drugs (single six-monthly or two three-monthly injections) could safely tide them over this critical period. Such a reginen will protect the patient for an average of at least 11 months from pregnancy as it tends to occur after a lag of at least five months following the last injection.
Introduction
It has been previously shown that a polypeptide obtained by hydrolysis of ovine growth hormone is capable of inducing a fall in blood glucose in patients suffering from diabetes mellitus and potentiating insulin hypoglycaemia in normal subjects (Armstrong et al., 1969; Bornstein et al., 1969a) . Other studies (Bornstein et al., 1968a (Bornstein et al., , 1969b (Bornstein et al., , 1969c have shown that the action of this polypeptide (Ac-G) is limited to the reversal of the specific inhibition of glyceraldehyde-3-phosphate dehydrogenase, a-glycerophosphate dehydrogenase, and acetyl-CoA-carboxylase by a polypeptide (In-G) corresponding to another part of the growth horrnone sequence. Thus it appeared important to demonstrate the presence of In-G in normal human plasma and to determine whether raised levels of this polypeptide were present in the plasma of diabetic patients.
Experimental
Blood was obtained, after 10 hours' fasting, fromn 58 volunteers comprising 16 normal subjects, 9 juvenile onset diabetics, 26 maturity onset diabetics, 3 cases of pancreatic diabetes, and 4 hypophysectomized diabetics. If patients were receiving treatment it was stopped 24 hours before the taking of blood.
The red cells were removed by centrifuging, 10 ml of plasma was acidified to pH 2-3 and ultrafiltered through Monash University, Clayton, Victoria 3168, Australia glyceraldehyde-3-phosphate dehydrogenase, a-glycerophosphate dehydrogenase, and acetyl-CoA-carboxylase, all other enzymes tested not being inhibited. The purified fractions from pooled plasma were tested on a number of enzymes and the results in Table II show that, for the enzymes tested, only the relevant ones were inhibited.
(3) Reversal of Inhibition by an Authentic Sample of Ac-G. The results of the effect of a sample of ovine Ac-G on the inhibition of glyceraldehyde-3-phosphate dehydrogenase produced by the crude plasma extracts are given in Table III , and it is seen that partial reversal was obtained. 
